Intended for healthcare professionals

Rapid response to:

News

Collaboration with drug industry won’t affect clinical decisions, says new guide

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2489 (Published 02 April 2012) Cite this as: BMJ 2012;344:e2489

Rapid Response:

Re: Collaboration with drug industry won’t affect clinical decisions, says new guide

I would like to endorse the views of Wendy Rogers, Tamara Zutlevics, Melissa Raven, and Jon Jureidini on the 'new guide to promote collaboration between healthcare organisations and the drug industry.'(1) I share their conclusion that 'this Guidance refuses to take seriously the challenging issue of conflicts of interest and does nothing to improve ethics or transparency. It is deeply disappointing.'

My own experience has been that education and marketing remain entangled and that 'transparency' is often claimed but is less often a reality.(2)

(1) BMJ Rapid Response: Re: Collaboration with drug industry won’t affect clinical decisions, says new guide. Wendy Rogers, Tamara Zutlevics, Melissa Raven, and Jon Jureidini

(2) BMJ 2011;343:d7375 System for disclosing hospitality should be transparent. 15 Nov 2011

Competing interests: No competing interests

18 April 2012
Peter J. Gordon
Old Age Psychiatrist
NHS
Forth Valley